Xi Jin
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 14
- Cancer Genomics and Diagnostics 10
- Cancer-related molecular mechanisms research 10
- Cancer, Lipids, and Metabolism 7
- Oncology 30
- HER2/EGFR in Cancer Research 14
- Cancer Immunotherapy and Biomarkers 6
Xi Jin
78 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 1.0k
- Oncology 775
- Pulmonary and Respiratory Medicine 668
- Molecular Biology 1.3k
- Immunology 326
Countries citing papers authored by Xi Jin
This map shows the geographic impact of Xi Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Jin more than expected).
Fields of papers citing papers by Xi Jin
This network shows the impact of papers produced by Xi Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Jin. The network helps show where Xi Jin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xi Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 14 | |
| 8 | 2024 | 23 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 32 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 37 | |
| 14 | 2023 | 14 | |
| 15 | 2022 | 37 | |
| 16 | 2021 | 32 | |
| 17 | 2021 | 62 | |
| 18 | 2021 | 41 | |
| 19 | 2020 | 18 | |
| 20 | 2016 | 157 |
About Xi Jin
Xi Jin is a scholar working on Cancer Research, Oncology, Complementary and Manual Therapy, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 83 papers that have together received 2.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (14 papers), Cancer Genomics and Diagnostics (10 papers), Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers), Advanced Breast Cancer Therapies (7 papers), Cancer, Lipids, and Metabolism (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (775 citations), Pulmonary and Respiratory Medicine (668 citations), Molecular Biology (1.3k citations) and Immunology (326 citations). Xi Jin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yi‐Zhou Jiang, Da‐Qiang Li, Zhi‐Ming Shao, Xiao‐En Xu, Ding Ma, Zhi‐Ming Shao, Yi-Zhou Jiang, Ke‐Da Yu, Yi‐Rong Liu and Gen‐Hong Di. Their work appears in journals such as Cancer Research, World Journal of Gastroenterology, BMC Cancer, Journal for ImmunoTherapy of Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.